It was a challenging year for many publicly held contract testing lab companies, which provide a variety of analytical testing as well as other services across a range of industries. With networks of labs worldwide and extensive testing capabilities, such companies are major customers for analytical instrumentation and lab products. Their acquisition activities, lab expansions […]

Currency fluctuations and economic turbulence not only produced a shift among IBO’s 2015 list of the top 30 analytical and life science instrument, aftermarket and lab product companies, but also yielded a calendar year sales decline when translated into US dollars. Total sales for the top 30 companies (see page 6) as reported in US […]

Despite indications that the global economy is continuing to slow, the outlook for sales growth within the instrument and lab product industry is positive. In late October, 15 industry executives completed the online IBO Business Climate Survey. The respondents were IBO subscribers and other solicited participants, each representing a unique company or business unit. The […]

Calendar year second quarter organic growth continued at a strong pace for major US publicly held instrument and laboratory product companies. However, currency headwinds, as well as weakness in industrial markets and Japan expunged organic growth. Currency reduced gains by about 7%, resulting in roughly flat second quarter average sales growth. Pharmaceutical and biotechnology markets […]

At Pittcon, IBO took the opportunity to talk to executives at four of the analytical-instrument and laboratory-product industry’s largest companies, PerkinElmer, Shimadzu Scientific Instruments (SSI) (the US-based division of Japan’s Shimadzu), Thermo Fisher Scientific and Waters, to discuss challenges and opportunities for both their businesses and the instrument industry in general. Asked about challenges this […]

As is usual for our annual forecast issue, IBO selects a firm from our industry as “company of the year.” In designating the company of the year, IBO recognizes an analytical- and life science–instrument maker that has accomplished technical, operational and financial achievements. Such achievements are a function of strong financial performance, market leadership, innovative […]

Merck KGaA and Sigma-Aldrich Consolidation continued in the lab-products market, as less than a year after Thermo Fisher Scientific’s purchase of Life Technologies (see IBO 2/15/14), Merck KGaA announced a $17 billion deal to buy Sigma-Aldrich (see IBO 9/30/14). The deal highlights the importance of scale and diversification and transforms Merck/EMD Millipore into a major […]

A More Focused Approach As economic headwinds in China, industrial and selected government markets continued in 2014, several analytical-instrument and lab-product companies took steps to focus on a narrower set of businesses and product lines, in some cases, divesting assets and, in other cases, consolidating their positions. Among the year’s most prominent product-line exits were […]